Sebastian Horner
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia.
Journal: Frontiers in immunology
Published: October 20, 2025
Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity.
Journal: Cell reports
Published: February 13, 2025
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescence.
Journal: Cancer immunology, immunotherapy : CII
Published: July 08, 2024
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 06, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
Journal: Journal for immunotherapy of cancer
Published: February 06, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
Journal: Journal of cancer research and clinical oncology
Published: November 17, 2021
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestion.
Journal: Biotechnology and bioengineering
Published: February 01, 2021
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies.
Journal: Journal for immunotherapy of cancer
Published: April 09, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.
Journal: EMBO molecular medicine
Published: December 13, 2019
Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery.
Journal: Angewandte Chemie (International ed. in English)
Published: June 22, 2016
Last Updated: 09/26/2026